Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Michel Gasana"'
Autor:
Jean Claude S. Ngabonziza, Leen Rigouts, Gabriela Torrea, Tom Decroo, Eliane Kamanzi, Pauline Lempens, Aniceth Rucogoza, Yves M. Habimana, Lies Laenen, Belamo E. Niyigena, Cécile Uwizeye, Bertin Ushizimpumu, Wim Mulders, Emil Ivan, Oren Tzfadia, Claude Mambo Muvunyi, Patrick Migambi, Emmanuel Andre, Jean Baptiste Mazarati, Dissou Affolabi, Alaine N. Umubyeyi, Sabin Nsanzimana, Françoise Portaels, Michel Gasana, Bouke C. de Jong, Conor J. Meehan
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 27, Iss , Pp 100299- (2022)
Summary background: Multidrug-resistant (MDR) tuberculosis (TB) poses an important challenge in TB management and control. Rifampicin resistance (RR) is a solid surrogate marker of MDR-TB. We investigated the RR-TB clustering rates, bacterial populat
Externí odkaz:
https://doaj.org/article/8c83389e22714bf5b35ec4ced1dcdb5e
Autor:
Valérie Schwœbel, Arnaud Trébucq, Zacharie Kashongwe, Alimata S. Bakayoko, Christopher Kuaban, Juergen Noeske, Souleymane H. Harouna, Mahamadou B. Souleymane, Alberto Piubello, François Ciza, Valentin Fikouma, Michel Gasana, Martial Ouedraogo, Martin Gninafon, Armand Van Deun, Elisa Tagliani, Daniela M. Cirillo, Kobto G. Koura, Hans L. Rieder
Publikováno v:
EClinicalMedicine, Vol 20, Iss , Pp - (2020)
Background: Treatment outcomes of the shorter regimen for rifampicin-resistant tuberculosis are not completely established. We report on these outcomes two years after treatment completion among patients enrolled in an observational cohort study in n
Externí odkaz:
https://doaj.org/article/5ef7adc6d97a49b6a696aab540072424
Autor:
Patrick Migambi, Michel Gasana, Claude Bernard Uwizeye, Eliane Kamanzi, Vedaste Ndahindwa, Nico Kalisvaart, Eveline Klinkenberg
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231372 (2020)
BackgroundRwanda conducted a national tuberculosis (TB) prevalence survey to determine the magnitude of TB in the country and determine to what extent the national surveillance system captures all TB cases. In addition we measured the patient diagnos
Externí odkaz:
https://doaj.org/article/d1a6507e87bf4abcb43bfa20bf816979
Autor:
Jean Claude Semuto Ngabonziza, Willy Ssengooba, Florence Mutua, Gabriela Torrea, Augustin Dushime, Michel Gasana, Emmanuel Andre, Schifra Uwamungu, Alaine Umubyeyi Nyaruhirira, Dufton Mwaengo, Claude Mambo Muvunyi
Publikováno v:
BMC Infectious Diseases, Vol 16, Iss 1, Pp 1-7 (2016)
Abstract Background Tuberculosis control program of Rwanda is currently phasing in light emitting diode-fluorescent microscopy (LED-FM) as an alternative to Ziehl-Neelsen (ZN) smear microscopy. This, alongside the newly introduced Xpert (Cepheid, Sun
Externí odkaz:
https://doaj.org/article/9e0a5b1c6ca543d79454a6a3bfbf575d
Autor:
Kenneth Turinawe, Greet Vandebriel, David W Lowrance, Francois Uwinkindi, Philippe Mutwa, Kimberly R Boer, Grace Mutembayire, David Tugizimana, Sabin Nsanzimana, Eric Pevzner, Andrea A Howard, Michel Gasana
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163462 (2016)
The World Health Organization (WHO) 2010 guidelines for intensified tuberculosis (TB) case finding (ICF) among people living with HIV (PLHIV) includes a recommendation that PLHIV receive routine TB screening. Since 2005, the Rwandan Ministry of Healt
Externí odkaz:
https://doaj.org/article/0233ecf67d19458693caf9419706992e
Autor:
Alaine Umubyeyi Nyaruhirira, Martine Toussaint, Bennett Nemser, Greet Vandebriel, Michel Gasana, Yanis Ben Amor
Publikováno v:
The Pan African Medical Journal, Vol 21, Iss 198 (2015)
INTRODUCTION: Ziehl-Neelsen (ZN) bright-field microscopy is time-consuming, with poor sensitivity, even under optimal conditions. Introduction of Primo StariLED fluorescent microscopy (FM) may improve TB case finding at referral hospitals in Rwanda.T
Externí odkaz:
https://doaj.org/article/2498c051dfce42cc921641dc9d85ca22
Autor:
Claude Rutanga, David W Lowrance, John E Oeltmann, Grace Mutembayire, Matt Willis, Claude Bernard Uwizeye, Ruton Hinda, Chitou Bassirou, Steve Gutreuter, Michel Gasana
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124485 (2015)
Data are limited regarding tuberculosis (TB) and latent TB infection prevalence in Rwandan health facilities.We conducted a cross-sectional survey among healthcare workers (HCWs) in Kigali during 2010. We purposively selected the public referral hosp
Externí odkaz:
https://doaj.org/article/443f724dd05743538bb07033e77259c3
Autor:
Agnes Binagwaho, Roger Bate, Michel Gasana, Corine Karema, Yves Mucyo, John Patrick Mwesigye, Floribert Biziyaremye, Cameron T Nutt, Claire M Wagner, Paul Jensen, Amir Attaran
Publikováno v:
PLoS Medicine, Vol 10, Iss 7, p e1001476 (2013)
Externí odkaz:
https://doaj.org/article/4a790891ba1743b4ad9a53e89b9d3639
Autor:
Felix R Kayigamba, Mirjam I Bakker, Veronicah Mugisha, Ludwig De Naeyer, Michel Gasana, Frank Cobelens, Maarten Schim van der Loeff
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e73501 (2013)
BACKGROUND: Adherence to treatment and sputum smear conversion after 2 months of treatment are thought to be important for successful outcome of tuberculosis (TB) treatment. METHODS: Retrospective cohort study of new adult TB patients diagnosed in th
Externí odkaz:
https://doaj.org/article/df91c8a8a0d344eda5ea15f529528d1b
Autor:
Bouke C. de Jong, Lies Laenen, Alaine Nyaruhirira Umubyeyi, Leen Rigouts, Conor J. Meehan, Yves Mucyo Habimana, Emil Ivan, Tom Decroo, Oren Tzfadia, Michel Gasana, Dissou Affolabi, Wim Mulders, Belamo E. Niyigena, Gabriela Torrea, Claude Mambo Muvunyi, Cécile Uwizeye, Jean Claude Semuto Ngabonziza, Françoise Portaels, Emmanuel André, Eliane Kamanzi, Aniceth Rucogoza, Pauline Lempens, Bertin Ushizimpumu, Patrick Migambi, Jean Baptiste Mazarati, Sabin Nsanzimana
Publikováno v:
SSRN Electronic Journal.
Background: Rifampicin-resistance (RR) poses an important challenge in tuberculosis (TB) management and control. Understanding the driving factors behind the rising numbers of RR-TB is important for developing appropriate control strategies. Methods: